Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Preformulation/Formulation Project Initiation Form: Client Information

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

A Pharmaceutical Development Company.

PREFORMULATION/FORMULATION PROJECT INITIATION FORM


CLIENT INFORMATION:
Contact Name: Title: Mailing Address: Phone #: Email address: Salutation (Mr., Ms., Dr.,): Company Name: City, State, Zip Code: Fax #: Company website:

IRVINE AREA MANAGER:


Contact Name: Title: Mailing Address: Phone #: Email address: Charles Petersen Dir., Formulation Development 10 Vanderbilt 949-951-4425 charles.petersen@irvinepharma.com Salutation (Mr., Ms., Dr., ): Company Name: City, State, Zip Code: Fax #: Company website: Dr. Irvine Pharmaceutical Services Irvine, CA 92618 949-951-9224 http://www.irvinepharma.com

NATURE OF WORK:
cGMP Method Development GC/MS LC/MS ELISA CE Gel Electrophoresis non cGMP AAA Extractables/Leachables Method Validation Cleaning Validation Method Optimization Method Feasibility Extend to Stability Preformulation Formulation API Characterization Other (please describe)

PRODUCT INFORMATION:
Name of Product: Product Description: (# of strengths / # of lots) Product Matrix DPI Nebulized MDI Nasal Lyophile Solution Suspension Capsule/ Tablet Other (please describe) Finished Dosage Form: Packaging Configuration: Dosage Form Strength: N Excipients: Development Phase Pre-IND I II III FDA Approved Other (please describe)

Placebo included? Y N API: Crystaline: Y N Aqueous Solubility: Y Hydroscopic: Y N Y N Stable: Sensitive to Light: Y PKa Value: Salt Form: Finished Dosage Form:

N Value:

TECHNICAL BACKGROUND:
Physical and Chemical Properties Previous Work at Irvine Special Equipment Needs? Identify ___________________________________________________________________________

1 of 2

A Pharmaceutical Development Company.

ANALYTICAL DEVELOPMENT DETAILS:


Method Development Characteristics: Method will be provided by client Type of Method: Assay Related Substances Stability-Indicating Preservative CE Method Validation Characteristics: Linearity Accuracy Precision Range Specificity Robustness System Suitability Intermediate Precision Limit of Detection Limit of Quantification Standard (Sample) solution stability Other (please describe):

Gel Identification SEC Inorganic Residues Other:

SAFETY INFORMATION:
Hazardous Yes No If yes, list type(s): Mass/volume to be sent: Special Handling Requirements: Unknown DEA Controlled No X I II III IV V

Please attach MSDS (required).

STANDARDS, COLUMNS, AND RAW DATA:


Reference Standards provided by: Client Irvine* Notes: ___________________________ Reference Standards characterized by: Client Irvine * ___________________________ Columns provided by: Client Irvine * ___________________________ * Project specific materials, purchased through Irvine Pharmaceutical Services, will be charged to Client at Irvine invoiced price

QUALITY ASSURANCE:
Full QA Review Peer Review Other: ____________________________________________________________

FINAL REPORT:
Irvine Template Client Template Other: ____________________________________________________________

TECH TRANSFER:
Back to client To Irvine AC Other: ____________________________________________________________

DISPOSAL OF SAMPLES:
Standard (30 days post report): Special Handling (return to client): Attention: _________________________________ Address: _________________________________ _________________________________ Client Shipping Account Number: _____________________

ADDITIONAL NOTES (attach other pages as needed):

2 of 2

You might also like